medline.ch Onkologie Gynäkologische Tumoren

	A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer. Front Oncol Luo S, Lin R, Lin H, Zhan Z, Wu X, Tang L, Huang X, Liu Y, Li P, Yao J, Wu P, Liao X. PMID: 41717413 [PubMed]
	Postoperative Management After Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer Syndrome: A Narrative Review on Balancing Oncologic Benefit and Quality of Life. Cureus Ishida H, Takashima A. PMID: 41717173 [PubMed]
	Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study. Cureus Suizu E, Koyanagi T, Saga Y, Takahashi Y, Tamura K, Taneichi A, Takei Y, Mizukami H, Fujiwara H. PMID: 41717160 [PubMed]
	The association between the Dietary Inflammatory Index and breast cancer risk: an updated systematic review and meta-analysis. Front Nutr Wang C, Zhou Q, Chen L, Zhai C. PMID: 41717029 [PubMed]
	Depth of Invasion of 13â€‰mm or Greater Accurately Predicted the Risk of Having a Node Positivity in Lymphadenectomy for Squamous Vulvar Cancer. J Obstet Gynaecol Res Albuquerque RC, Sousa SS, Tozatti GV, Boneto B, Torres JC, Vale DB. PMID: 41716116 [PubMed - indexed for MEDLINE]
	An Automated Hybrid Deep Learning-based Model for Breast Cancer Detection using Mammographic Images. Curr Med Imaging Gandhi O, Rao SNT, Prasad MHMK. PMID: 41716062 [PubMed - as supplied by publisher]
	Role and underlying mechanisms of miRâ€‘200 family in breast cancer (Review). Int J Oncol Liu J, Du H, Shi Y. PMID: 41716019 [PubMed - indexed for MEDLINE]
	Change in mammographic density as a potential predictor of cancer recurrence after breast conservation surgery and adjuvant endocrine therapy: results of the MEDICI study. Breast Cancer Res Savaridas SL, Marshall A, Ali K, Astley SM, Evans AJ, Halling-Brown M, Vinnicombe S, Warwick VR, Whelehan P, Drummond S, Ebsim R, Healy NA, Nash J, Muscat E, Muthyala S, Sharma A, Telesca M, Dunn J. PMID: 41715137 [PubMed - as supplied by publisher]
	Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer: a retrospective cohort study using inverse probability of treatment weighting. World J Surg Oncol Su H, Tian M, Wang Y, Li Y, Shan Y, Jin Y, Wang T, Feng F. PMID: 41715093 [PubMed - as supplied by publisher]
	A cross-sectional study of coping strategies among a sample of women with breast cancer in South-South, Nigeria. BMC Cancer Edet B, Sarimiye FO, Essien E, Lu B, Harris P, Azimi J, Lalji-Mawji S, Udosen J, Edet C, Olagunju TO, Kolawole OF, Ostermeyer BK, Chaimowitz GA, Olagunju AT. PMID: 41715011 [PubMed - as supplied by publisher]
	Longitudinal assessment of chemotherapy-induced peripheral neuropathy in women undergoing taxane-based treatment for breast cancer: a prospective observational study. BMC Cancer Brownson-Smith R, Carr J, Orange ST, Cresti N, Saxton JM, Temesi J. PMID: 41715001 [PubMed - as supplied by publisher]
	BreasTransNeXt: An Enhanced Multi-Module Vision Transformer For Early Breast Cancer Diagnosis. J Imaging Inform Med Acikgoz H, Aytekin A, Gezici S. PMID: 41714572 [PubMed - as supplied by publisher]
	Effect of an integrated mHealth supportive care program on symptom burden and self-efficacy in post-treatment breast cancer survivors: a randomized controlled trial. J Cancer Surviv Yao Y, Liu X, Huang Y, Cheng ASK, Cheng Q, Wu H, Xiao R. PMID: 41714554 [PubMed - as supplied by publisher]
	Efficacy of chimeric antigen receptor natural killer cells in treatment of ovarian cancer. A meta-analysis of pre-clinical studies. Immunol Res Ahmed N, Jabeen J, Rehman M, Noor S, Tahseen S, Qamar A, Anas M, Khalid MM, Ahmad T, Wang W, Lyu L. PMID: 41714550 [PubMed - indexed for MEDLINE]
	Nanotherapeutics to Overcome Chemotherapy Resistance in Ovarian Cancer. Pharm Res Mahira S, Sathe P, Krishnan S, Shaik R, Pamula V. PMID: 41714544 [PubMed - as supplied by publisher]
	Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775. J Immunother Cancer Makker V, Colombo N, Casado A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Yonemori K, Kim YM, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Kristeleit R, Nishio S, Suzuki S, Guerra Alía EM, Sanli UA, Selle F, Shikama A, Martínez Rodríguez JL, Arik Z, Arican A, Sebastianelli A, Yu Z, McKenzie J, Kruger S, Meng R, Okpara CE, Lorusso D. PMID: 41714113 [PubMed - indexed for MEDLINE]
	Breast cancer screening best practices: a Canadian multidisciplinary consensus-based approach for primary care providers. BMJ Open Pathak N, Corrado AM, Seely JM, Heisey R, Lofters A, Cil T, Sussman J, Zhong T, Amir E, Isenberg A, Nadler MB. PMID: 41713920 [PubMed - indexed for MEDLINE]
	MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study. Lancet Oncol Louis FM, van der Voort A, van Ramshorst MS, Daletzakis A, Mandjes IA, Kemper I, Agterof MJ, van der Steeg WA, Heijns JB, van Bekkum ML, Siemerink EJM, Kuijer PM, Scholten A, Wesseling J, Vrancken Peeters MTFD, Egeler MD, van de Poll-Franse LV, Mann RM, Sonke GS, Dutch Breast Cancer Research Group (BOOG). PMID: 41713473 [PubMed - as supplied by publisher]
	Cardiovascular and musculoskeletal health in breast cancer survivors. Maturitas Moore HCF. PMID: 41713085 [PubMed - as supplied by publisher]
	Adjuvant Chemotherapy in Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-analysis. Obstet Gynecol Inayama Y, Higashiyama N, Yamaguchi K, Ogura J, Mizuno R, Taki M, Yamanoi K, Murakami R, Hamanishi J, Horikawa N, Furukawa TA, Mandai M. PMID: 41712944 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 324699

Seite 1 von 16235

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung